368 related articles for article (PubMed ID: 33123090)
1. Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival.
Krajewska J; Kukulska A; Oczko-Wojciechowska M; Kotecka-Blicharz A; Drosik-Rutowicz K; Haras-Gil M; Jarzab B; Handkiewicz-Junak D
Front Endocrinol (Lausanne); 2020; 11():571421. PubMed ID: 33123090
[TBL] [Abstract][Full Text] [Related]
2. Cancer screening activity results in overdiagnosis and overtreatment of papillary thyroid cancer: A 10-year experience at a single institution.
Kaliszewski K; Diakowska D; Wojtczak B; Rudnicki J
PLoS One; 2020; 15(7):e0236257. PubMed ID: 32692768
[TBL] [Abstract][Full Text] [Related]
3. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
[No Abstract] [Full Text] [Related]
4. Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults.
Horiguchi K; Yoshida Y; Iwaku K; Emoto N; Kasahara T; Sato J; Shimura H; Shindo H; Suzuki S; Nagano H; Furuya F; Makita N; Matsumoto F; Manaka K; Mitsutake N; Miyakawa M; Yokoya S; Sugitani I
Endocr J; 2021 Jul; 68(7):763-780. PubMed ID: 33762511
[TBL] [Abstract][Full Text] [Related]
5. Papillary thyroid microcarcinoma: Is active surveillance always enough?
Sutherland R; Tsang V; Clifton-Bligh RJ; Gild ML
Clin Endocrinol (Oxf); 2021 Dec; 95(6):811-817. PubMed ID: 34021503
[TBL] [Abstract][Full Text] [Related]
6. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
7. From Overdiagnosis to Overtreatment of Low-Risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients.
Jensen CB; Saucke MC; Francis DO; Voils CI; Pitt SC
Thyroid; 2020 May; 30(5):696-703. PubMed ID: 31910092
[No Abstract] [Full Text] [Related]
8. Effect of a Change in Papillary Thyroid Cancer Terminology on Anxiety Levels and Treatment Preferences: A Randomized Crossover Trial.
Nickel B; Barratt A; McGeechan K; Brito JP; Moynihan R; Howard K; McCaffery K
JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):867-874. PubMed ID: 30335875
[TBL] [Abstract][Full Text] [Related]
9. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.
Sakai T; Sugitani I; Ebina A; Fukuoka O; Toda K; Mitani H; Yamada K
Thyroid; 2019 Jan; 29(1):59-63. PubMed ID: 30560718
[TBL] [Abstract][Full Text] [Related]
10. Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.
Sugitani I; Ito Y; Miyauchi A; Imai T; Suzuki S
Thyroid; 2019 Nov; 29(11):1563-1571. PubMed ID: 31441377
[No Abstract] [Full Text] [Related]
11. Terminology Change for Small Low-Risk Papillary Thyroid Cancer As a Response to Overtreatment: Results from Three Australian Community Juries.
Shih P; Nickel B; Degeling C; Thomas R; Brito JP; McLeod DSA; McCaffery K; Carter SM
Thyroid; 2021 Jul; 31(7):1067-1075. PubMed ID: 33238815
[No Abstract] [Full Text] [Related]
12. Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?
Leboulleux S; Tuttle RM; Pacini F; Schlumberger M
Lancet Diabetes Endocrinol; 2016 Nov; 4(11):933-942. PubMed ID: 27550849
[TBL] [Abstract][Full Text] [Related]
13. Understanding the natural history of papillary thyroid cancer: Case series.
Lin JK; Sakoda LC; Darbinian J; Chiao W; Calixto N; Gurushanthaiah D; Wang KH; Durr M
Head Neck; 2019 Dec; 41(12):4164-4170. PubMed ID: 31584743
[TBL] [Abstract][Full Text] [Related]
14. Can Active Surveillance be an Alternative to Surgery in Papillary Thyroid Microcarcinoma?: The Current Situation Worldwide.
Aygün N; İşgör A; Uludağ M
Sisli Etfal Hastan Tip Bul; 2018; 52(4):233-243. PubMed ID: 32774084
[TBL] [Abstract][Full Text] [Related]
15. Active surveillance of low-risk papillary thyroid microcarcinoma.
Sugitani I
Best Pract Res Clin Endocrinol Metab; 2023 Jan; 37(1):101630. PubMed ID: 35256266
[TBL] [Abstract][Full Text] [Related]
16. Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma: a SEER database analysis.
Liu C; Chen T; Zeng W; Wang S; Xiong Y; Liu Z; Huang T
Sci Rep; 2017 Sep; 7(1):11412. PubMed ID: 28900207
[TBL] [Abstract][Full Text] [Related]
17. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
18. Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea.
Oh HS; Ha J; Kim HI; Kim TH; Kim WG; Lim DJ; Kim TY; Kim SW; Kim WB; Shong YK; Chung JH; Baek JH
Thyroid; 2018 Dec; 28(12):1587-1594. PubMed ID: 30226447
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
Sabet A; Binse I; Grafe H; Ezziddin S; Görges R; Poeppel TD; Bockisch A; Rosenbaum-Krumme SJ
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127
[TBL] [Abstract][Full Text] [Related]
20. Molecular Aberrance in Papillary Thyroid Microcarcinoma Bearing High Aggressiveness: Identifying a "Tibetan Mastiff Dog" From Puppies.
Li D; Gao M; Li X; Xing M
J Cell Biochem; 2016 Jul; 117(7):1491-6. PubMed ID: 26841328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]